Diabetic Macular Edema (DME) Withdrawn Phase 2 / 3 Trials for Bevacizumab (DB00112)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Withdrawn2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02229175Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular EdemaTreatment